Resources:

Find resources by:

Sort by:

Date Resource A-Z Random

Resources from the last:

Box size:

Filer text box:

Topic familiarity:

Grid Layout:

Collections that use this topic:

Collection topics:

Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid

Neuroendocrinology NETs

Pituitary Brain Tumours Hypothalamus Kisspeptin ACTH TSH Cushing's NETs Paraganglioma Vasopressin Neuroendocrine Growth Somatostatin

Dental magnets for obesity treatment

Save the date for NETs Basics Day!

Call for proposals in disorders of bone metabolism

New funding opportunities for the EME programme

Engineers control ‘robotic sperm’ with magnets (BBC News, 2 June 2014)

NIHR Themed Call: Long-term Conditions in Children and Young People

NIHR Cochrane Programme Grants

For the record: Can magnets reduce the symptoms of menopause?

Cochrane Review Incentive Scheme 2010

Resource not read: Query Programmes

Resource not read: Query You and Your Hormones

Progress in understanding pancreatic NETs

177Lu-Dotatate in advanced midgut NETs

General news update

CHIEF EXECUTIVE NEWS

When primary hyperparathyroidism comes as good news

The expression of oxytocin receptor (OXTR) in metastatic pancreatic neuroendocrine tumors (PNETs)

Adrenalectomy (ADX) increases the activation of hypothalamic and nucleus of the solitary tract (NTS) neurons related with food intake control during endotoxemia

Second neoplasms in patients with sporadic neuroendocrine neoplasms (NENs)

A single centre analysis of the management of appendiceal neuroendocrine neoplasms (NENs) including goblet cell carcinoids (GCC)

Metabolic and surgical outcomes of adult patients with craniopharyngiomapatients undergoing extended transsphenoidal surgery (ETS) at a referral center

How Do I\.\.Manage Diarrhoea in Patients with NETs

Modality to detect pancreatic NETS in MEN1: EUS or MRI?

Where NETs fit in with the 100,000 genome project

12.7. The shared risk of diabetes between dog and cat owners and their pets: register based cohort study

Management of multiple endocrine neoplasia type 1 (MEN1) and sporadic pancreatic neuroendocrine tumours (PNETS) in relation to the clinical guidelines: a single centre audit

Thoracic and gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) and the ectopic ACTH syndrome (EAS)

Spatial profiling of neuro-immune interactions in gastroenteropancreatic NETs

Nutritional assessment and vitamin deficiencies in patients with NETs

Second neoplasms in patients with sporadic neuroendocrine neoplasms (NENs)

Current guidelines for the classification of net

Type I gastric NETs: Surveillance, Endoscopic Resection or Surgery

Two cases of ectopic ACTH in advanced NETs

Evaluation of vegf and endocan/esm-1 expression in pnets and correlation with Ki67 and prognosis

Enteropancreatic neuroendocrine tumours (EP- NETS): current concept and controversies; a systematic review

NP-101 in combination with nivolumab and ipilimumab in metastatic extra-pulmonary neuroendocrine carcinomas (EP-NECs): a pilot study

Nutrition support in GEP-NETs: an underestimated co-worker

Somatostatin analogue treatment is associated with lack of progression of pNETs <20mm in size in patients with MEN1

Serotonin, ATRX and DAXX as differential diagnostic markers of neuroendocrine tumours (NETs) in the sellar region. An immunohistochemical study in a large series of pituitary adenomas and in a non-pituitary NET

14.9. How to read numbers: a guide to statistics in the news (and knowing when to trust them)

Does concealment of bad news stimulate the HPA or the SAS axis?

Nutrition in patients with gastro-entero-pancreatic (GEP) neuroendocrine tumours (NETs) and NETs of unknown primary

Clinical studies of patients with neuroendocrine tumours (NETs)

Tumor biology and classification of NET

Peptide receptor radionuclide therapy and NETs: how to select patients?

Influence of Tumor Microenviroment in response modulation to treatment in human BP-NENs

Endoscopic submucosal dissection (ESD) of gastric and rectal neuroendocrine tumours (NETs)

Tumor behaviour in neuroendocrine tumors (NETs) of unknown primary versus known primary site location

Incidentally discovered nonfunctioning pancreatic NETs: Surgery or not? - FOR

CDK4/6 and MEK are actionable, therapeutic targets in pancreatic and lung neuroendocrine tumors (NETs)

Evolution of mesenteric metastasis in small intestinal neuroendocrine tumours (SI-NETs)

A role for radionuclide therapy for high-grade NETs

Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a case-control study from NETTARE Unit

Novel approaches in the treatment of NET

Patient-reported time to diagnosis of neuroendocrine tumors (NETs) in Europe: results from the first global NET patient survey: a collaboration between the International Neuroendocrine Cancer Alliance (INCA) and Novartis

Clinical and pre-clinical studies of neuroendocrine tumours (NETs) in multiple endocrine neoplasia type 1 (MEN1), and evaluation of MEN1 gene replacement therapy for MEN1-associated NETs.

Germline Pathogenic Variants in Patients with High-Grade (G3) Metastatic Gastroenteropancreatic (GEP) Neuroendocrine Neoplasms (NENs)

Integrated genome-wide DNA methylation and mRNA expression analysis of pancreatic NETs

Management of GEP-NET tumors

The metabolic syndrome (MetS) in 2610 GH deficient (GHD) subjects before GH replacement: a KIMS (Pfizer International Metabolic Database) analysis

Effects of debulking surgery, transarterial embolisation (TAE) and transarterial chemoembolisation (TACE) on quality of life in patients with metastatic ileal and pancreatic neuroendocrine tumours (NETs)

Malnourished patients with GEP-NETs, how does this develop in 5 years

PEI, PERT & NENs: the impact of PERT shortages and implications for practice

Fibroblast-mediated modulation of GI-NETs: Implications for drmg response and tumor invasion

The proinflammatory molecule, VAP-1, is enriched in the stroma of midgut NETs and plaques of carcinoid heart disease valves

Efficacy and safety of <sup>90</sup>Y-DOTATATE therapy in neuroendocrine tumours (NETs)

Webinar 9 - Neuroendocrine Tumours (NETs) and Multiple Endocrine Neoplasia 1 & 2 (MEN1&2)